| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.07T | 5.92T | 5.75T | 5.67T | 5.45T |
| Gross Profit | 2.59T | 2.51T | 2.43T | 2.41T | 2.46T |
| EBITDA | 1.75T | 1.78T | 1.62T | 1.71T | 1.78T |
| Net Income | 707.11B | 685.68B | 637.87B | 679.11B | 672.49B |
Balance Sheet | |||||
| Total Assets | 19.06T | 16.88T | 14.15T | 11.92T | 11.08T |
| Cash, Cash Equivalents and Short-Term Investments | 1.08T | 944.14B | 907.73B | 504.62B | 819.05B |
| Total Debt | 5.38T | 4.69T | 2.66T | 1.66T | 1.74T |
| Total Liabilities | 13.47T | 11.23T | 8.35T | 6.25T | 5.57T |
| Stockholders Equity | 5.08T | 5.13T | 5.25T | 5.13T | 4.98T |
Cash Flow | |||||
| Free Cash Flow | 1.21T | 958.47B | 1.12T | 834.45B | 1.04T |
| Operating Cash Flow | 1.61T | 1.36T | 1.64T | 1.23T | 1.47T |
| Investing Cash Flow | -1.09T | -1.28T | -820.24B | -739.43B | -767.35B |
| Financing Cash Flow | -544.46B | -5.76B | -462.97B | -671.76B | -721.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥559.13B | 22.73 | 15.67% | 1.31% | 9.02% | 21.15% | |
73 Outperform | ¥10.26T | 18.73 | ― | 3.99% | 7.55% | 3.27% | |
70 Outperform | ¥327.52B | 24.76 | 13.42% | 2.27% | 2.41% | 9.05% | |
63 Neutral | ¥18.85B | 24.80 | ― | ― | 25.92% | -10.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥12.74T | 11.58 | 11.22% | 3.36% | 5.14% | 5.49% | |
56 Neutral | ¥9.86T | 14.36 | 13.75% | 2.85% | 4.05% | 13.53% |